Nuvectra Corp (NVTR) Given Average Rating of “Hold” by Analysts

Nuvectra Corp (NASDAQ:NVTR) has received an average rating of “Hold” from the six analysts that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $12.00.

A number of research firms have weighed in on NVTR. Piper Jaffray Companies restated a “hold” rating and set a $12.00 target price on shares of Nuvectra in a report on Friday, November 3rd. ValuEngine upgraded Nuvectra from a “strong sell” rating to a “sell” rating in a report on Wednesday, January 31st. Finally, JMP Securities began coverage on Nuvectra in a report on Wednesday. They set an “outperform” rating for the company.

Shares of Nuvectra (NASDAQ NVTR) opened at $8.91 on Wednesday. The company has a current ratio of 2.90, a quick ratio of 2.72 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $121.15, a price-to-earnings ratio of -1.90 and a beta of -0.51. Nuvectra has a twelve month low of $5.76 and a twelve month high of $15.00.

A number of institutional investors have recently bought and sold shares of the business. Wells Fargo & Company MN lifted its holdings in Nuvectra by 1.3% during the second quarter. Wells Fargo & Company MN now owns 114,492 shares of the company’s stock worth $1,520,000 after buying an additional 1,495 shares during the period. Stifel Financial Corp lifted its holdings in Nuvectra by 6.2% during the second quarter. Stifel Financial Corp now owns 34,227 shares of the company’s stock worth $444,000 after buying an additional 1,999 shares during the period. Northern Trust Corp lifted its holdings in Nuvectra by 1.7% during the second quarter. Northern Trust Corp now owns 169,659 shares of the company’s stock worth $2,253,000 after buying an additional 2,811 shares during the period. Spark Investment Management LLC lifted its holdings in Nuvectra by 34.5% during the fourth quarter. Spark Investment Management LLC now owns 35,500 shares of the company’s stock worth $275,000 after buying an additional 9,100 shares during the period. Finally, FNY Partners Fund LP lifted its holdings in Nuvectra by 449.6% during the third quarter. FNY Partners Fund LP now owns 13,740 shares of the company’s stock worth $182,000 after buying an additional 11,240 shares during the period. Institutional investors own 48.41% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This piece was published by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of United States & international copyright law. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2018/02/14/nuvectra-corp-nvtr-given-average-rating-of-hold-by-analysts.html.

Nuvectra Company Profile

Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company’s Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company’s commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs.

Receive News & Ratings for Nuvectra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvectra and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply